Woman surrounded by cups of coffee with her head on her desk

Chronic fatigue is a debilitating condition characterized by persistent, overwhelming exhaustion that doesn't improve with rest. While everyone experiences tiredness occasionally, chronic fatigue significantly impairs daily functioning and quality of life for millions of people worldwide.

When fatigue persists for six months or longer and is accompanied by specific symptoms like post-exertional malaise, it may indicate myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) — a complex, multi-system illness that affects approximately 3.3 million adults in the United States alone. Understanding the differences between general fatigue and ME/CFS is crucial for proper diagnosis and treatment.

Table of Contents

  • What Is Chronic Fatigue?
  • Types and Classifications of Fatigue
  • Chronic Fatigue Syndrome (ME/CFS)
  • Causes and Risk Factors
  • Connection to Mental Health
  • Diagnosis and Assessment
  • Treatment Approaches
  • Living with Chronic Fatigue
  • When to Seek Professional Help
  • Frequently Asked Questions
  • How Therapy Can Help
  • References

What Is Chronic Fatigue?

Chronic fatigue is a complex disease that affects approximately 2 million people in the United States. Unlike ordinary tiredness that resolves with rest, chronic fatigue involves subjective symptoms that impair daily life and predict health-related events.

The condition manifests as both physical and mental exhaustion, often leaving individuals unable to perform routine activities they previously managed with ease. People with myalgic encephalomyelitis/chronic fatigue syndrome have exhaustion, stopping them from doing activities and having a big impact on everyday life.

Key Characteristics of Chronic Fatigue:

  • Duration: Persists for six months or longer
  • Severity: Significantly limits daily activities
  • Rest-resistant: Does not improve with sleep or rest
  • Multi-dimensional: Affects physical, cognitive, and emotional functioning
  • Unpredictable: Symptoms may fluctuate in intensity

Types and Classifications of Fatigue

Fatigue exists on a spectrum, ranging from temporary exhaustion to chronic, disabling conditions. Recent research has identified distinct categories:

General Fatigue

The prevalence of general fatigue (fatigue lasting < 6 months, or fatigue of unspecified duration) was 20.4% (95% CI, 16.7–25.0) in adults. This type typically:

  • Resolves with adequate rest
  • Has identifiable causes (poor sleep, overexertion)
  • Responds to lifestyle modifications

Chronic Fatigue

Chronic fatigue (fatigue lasting more than 6 months) affected 10.1% (95% CI, 8.2–12.5) of adults. Characteristics include:

  • Persistent exhaustion lasting over 6 months
  • Significant functional impairment
  • May occur with or without underlying medical conditions

Post-Infectious Fatigue

Following viral infections, some individuals develop persistent fatigue. A substantial percentage of patients with fatigue remain ill for many months with an illness similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), particularly after COVID-19 infections.

Chronic Fatigue Syndrome (ME/CFS)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) represents the most severe form of chronic fatigue. In 2021–2022, 1.3% of adults had myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The percentage of adults who had ME/CFS increased with age through ages 60–69 and then declined among those age 70 and older.

Core Diagnostic Criteria

Chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME), is a complex, multisystem disease commonly characterized by severe fatigue, cognitive dysfunction, sleep disturbances, autonomic dysfunction, and postexertional malaise, which severely impair activities of daily living.

The essential features include:

1. Substantial reduction in functioning lasting 6+ months

2. Post-exertional malaise (PEM) — They also have postexertional malaise, meaning they become more unwell after using even small amounts of energy

3. Unrefreshing sleep despite adequate duration

4. Cognitive impairment or orthostatic intolerance

Prevalence and Demographics

Recent CDC data reveals important demographic patterns:

  • White non-Hispanic (1.5%) adults were more likely to have ME/CFS compared with Asian non-Hispanic (0.7%) and Hispanic (0.8%) adults
  • Women are disproportionately affected (1.7%) compared to men (0.9%)
  • Adults with a family income less than 100% of the federal poverty level (2.0%) were more likely to have ME/CFS
  • The percentage of adults who had ME/CFS increased with increasing rurality of their place of residence

The Post-COVID Connection

We have therefore performed a systematic review and meta-analysis to determine the proportion of LC patients that satisfy ME/CFS diagnostic criteria. Research shows 51% (95% CI, 42%−60%) of LC patients satisfied ME/CFS diagnostic criteria, with fatigue, sleep disruption, and muscle/joint pain being the most common overlapping symptoms.

Causes and Risk Factors

The development of chronic fatigue and ME/CFS involves multiple interconnected factors:

Biological Mechanisms

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome has revealed:

  • Immune dysfunction: Altered cytokine profiles and immune responses
  • Metabolic abnormalities: Impaired cellular energy production
  • Neurological changes: Altered brain connectivity and function
  • Gut microbiome dysbiosis: Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients

Triggering Events

Common precipitating factors include:

  • Viral infections: Epstein-Barr virus, COVID-19, influenza
  • Physical trauma: Accidents, surgeries, injuries
  • Psychological stress: Major life events, chronic stress
  • Environmental factors: Toxin exposure, extreme temperatures

Genetic Susceptibility

Research indicates genetic factors may influence ME/CFS risk, though specific genes remain under investigation. Family clustering suggests hereditary components may contribute to susceptibility.

Connection to Mental Health

The relationship between chronic fatigue and mental health is complex and bidirectional. Compared with the control group, the CFS group had a higher prevalence of depression and anxiety disorder before the diagnosis of CFS.

Depression and Chronic Fatigue

Around 36% to 70% of patients experience clinical levels of depression [27,28] and 32% to 57% experience clinical levels of anxiety [29,30]. These lead to poorer prognosis. The connection involves:

  • Shared biological pathways: Inflammation affects both conditions
  • Symptom overlap: Fatigue is common in depression
  • Psychosocial impact: Disability from fatigue can trigger depression

Anxiety Disorders

Younger participants (13–24 years) reported experiencing feelings of depression, fear and anxiety about the future, hopelessness and sadness more frequently compared to older age groups. Specifically, a higher percentage of younger participants (66.7%) reported feelings of anxiety and fear.

Common anxiety manifestations include:

  • Fear about symptom worsening
  • Health-related anxiety
  • Social anxiety due to limitations
  • Anticipatory anxiety about activities

Impact on Quality of Life

Overall, ME/CFS led a third of the patients and half of the male patients to have suicidal thoughts. ME/CFS led to secondary depression in 14.8% of the patients. This underscores the critical need for comprehensive mental health support.

Diagnosis and Assessment

Diagnosing chronic fatigue and ME/CFS requires comprehensive evaluation, as outcomes are often poor due to delayed or misdiagnosis, inadequate clinician education, clinician bias, and misinformation regarding the diagnosis and treatment of the disease.

Clinical Assessment Tools

Healthcare providers use various instruments:

  • Fatigue severity scales: Measure impact on daily function
  • Symptom questionnaires: Track multiple symptoms over time
  • Activity logs: Document post-exertional symptoms
  • Cognitive assessments: Evaluate mental function changes

Differential Diagnosis

Other conditions must be ruled out, including:

  • Thyroid disorders
  • Sleep apnea
  • Autoimmune diseases
  • Vitamin deficiencies
  • Mental health conditions
  • Medication side effects

Laboratory Testing

While no definitive test exists for ME/CFS, testing helps exclude other causes:

  • Complete blood count
  • Comprehensive metabolic panel
  • Thyroid function tests
  • Inflammatory markers
  • Vitamin B12 and D levels

Treatment Approaches

In 2022, the systematic review... concluded that there is limited evidence on effective treatments for ME/CFS. However, management strategies focus on symptom relief and functional improvement.

Activity Management (Pacing)

A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Lessons learned for the long COVID pandemic emphasizes:

  • Energy envelope technique: Stay within available energy limits
  • Activity diaries: Track symptoms and identify triggers
  • Rest periods: Schedule regular breaks
  • Gradual adjustments: Modify activities based on symptoms

Pharmacological Interventions

While no FDA-approved treatments exist specifically for ME/CFS, medications may help manage symptoms:

  • Sleep medications: For unrefreshing sleep
  • Pain relievers: For muscle and joint pain
  • Orthostatic intolerance treatments: For blood pressure regulation
  • Antidepressants: When depression co-occurs

Complementary Approaches

Is there a role for traditional and complementary medicines in managing chronic fatigue? A systematic review of randomized controlled trials suggests potential benefits from:

  • Mindfulness and meditation
  • Gentle yoga or tai chi
  • Nutritional supplements (under medical guidance)
  • Acupuncture for symptom management

Emerging Therapies

Recent research explores:

  • Bright light therapy: A total of 36 patients were included in the study... recruitment took place between February 2021 and January 2024
  • Mitochondrial support: Targeting cellular energy production
  • Immune modulators: Addressing underlying immune dysfunction
  • Microbiome interventions: Restoring gut health

Living with Chronic Fatigue

Managing chronic fatigue requires comprehensive lifestyle adaptations:

Daily Management Strategies

  • Prioritize activities: Focus on essential tasks
  • Modify environment: Reduce sensory stimulation
  • Use assistive devices: Conserve energy where possible
  • Maintain routine: Establish predictable patterns

Social Support

  • Join support groups (online or in-person)
  • Educate family and friends about the condition
  • Communicate needs clearly
  • Build a healthcare team

Workplace Accommodations

  • Flexible scheduling
  • Work-from-home options
  • Reduced hours or workload
  • Ergonomic modifications

When to Seek Professional Help

Consult a healthcare provider if you experience:

  • Fatigue lasting over 6 months
  • Significant functional decline
  • Worsening symptoms after activity
  • Cognitive difficulties affecting work or relationships
  • Mood changes accompanying fatigue

Early intervention can improve outcomes and quality of life. A multidisciplinary approach involving primary care, specialists, and mental health professionals often provides the best results.

Frequently Asked Questions

Is chronic fatigue syndrome a real medical condition?

Yes, ME/CFS is recognized by major health organizations including the CDC, WHO, and NIH as a serious, complex multi-system disease. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic disease that impacts millions of people worldwide. The disease affects many body systems including the nervous, cardiovascular, and immune systems.

Can chronic fatigue be cured?

Currently, there is no cure for ME/CFS. Without a known cure, no specific curative medication, disability lasting years to being life-long, and disagreement among healthcare providers as to how to most appropriately treat these patients, ME/CFS patients are in need of assistance. However, symptoms can be managed, and some people experience improvement over time.

How is chronic fatigue different from being tired?

Unlike normal tiredness, chronic fatigue:

  • Doesn't improve with rest
  • Significantly impairs daily activities
  • Lasts 6 months or longer
  • Often worsens after physical or mental exertion
  • Is accompanied by other symptoms like cognitive difficulties

Can therapy help with chronic fatigue?

Yes, therapy can be beneficial for managing the psychological impact of chronic fatigue. Depression is often an example of the inflammatory response in certain people's central nervous system, and since inflammation may be part of CFS, we see this type of depression in some patients with CFIDS. Patients with CFS may have an element of situational depression because their lives are interrupted. Therapy helps with coping strategies, mood management, and adjusting to life changes.

Is chronic fatigue more common after COVID-19?

Yes, research shows a significant connection. Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: A report from the observational RECOVER-adult study indicates increased ME/CFS cases following COVID-19 infection, contributing to the long COVID phenomenon.

What lifestyle changes can help manage chronic fatigue?

Key lifestyle modifications include:

  • Implementing pacing strategies
  • Maintaining consistent sleep schedules
  • Following an anti-inflammatory diet
  • Gentle movement within limits
  • Stress reduction techniques
  • Creating a supportive environment

How Therapy Can Help

Working with a mental health professional can provide crucial support for individuals with chronic fatigue. Therapy offers:

Coping Strategy Development

Therapists help develop practical strategies for managing symptoms, adjusting to limitations, and maintaining quality of life despite chronic illness.

Emotional Support

Processing the grief, frustration, and anxiety that often accompany chronic fatigue is essential. Therapy provides a safe space to explore these emotions.

Relationship Navigation

Chronic fatigue affects relationships. Therapy can help improve communication with loved ones and address relationship challenges.

Cognitive-Behavioral Approaches

While not curative, cognitive-behavioral therapy (CBT) can help manage thoughts and behaviors that may worsen symptoms or interfere with coping.

Mind-Body Techniques

Therapists may teach relaxation techniques, mindfulness, and other approaches to manage stress and improve overall well-being.

If you're struggling with chronic fatigue, consider reaching out to a therapist who understands chronic illness. The GoodTherapy directory can help you find qualified professionals in your area who specialize in chronic health conditions and their psychological impact.

References:

  1. Bateman, L., Bested, A. C., Bonilla, H. F., Chheda, B. V., Chu, L., Curtin, J. M., Dempsey, T. T., Dimmock, M. E., Dowell, T. G., Felsenstein, D., Kaufman, D. L., Klimas, N. G., Komaroff, A. L., Lapp, C. W., Levine, S. M., Montoya, J. G., Natelson, B. H., Peterson, D. L., Podell, R. N.,... & Yellman, B. P. (2021). Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clinic Proceedings, 96(11), 2861–2878. https://doi.org/10.1016/j.maycp.2021.07.004
  2. Centers for Disease Control and Prevention. (2023). The systematic review report for diagnosis and treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Federal Register, 88(13). https://www.federalregister.gov/documents/2023/01/18/2023-00813/
  3. Chen, C., Yip, H. T., Leong, K. H., Yip, B. S., Yao, W. C., & Hung, C. L. (2023). Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: A population-based study in Taiwan. Journal of Translational Medicine, 21, 98. https://doi.org/10.1186/s12967-023-03886-1
  4. Cockayne, N. L., Duffy, S. L., Bonomally, R., English, A., Amminger, P. G., Mackinnon, A., Hickie, I. B., Naismith, S. L., & Hermens, D. F. (2022). Sleep in chronic fatigue syndrome and fibromyalgia: A systematic review and meta-analysis of polysomnographic data. Clinical Sleep Medicine, 18(6), 1547–1561. https://doi.org/10.5664/jcsm.9914
  5. Diamant, Z., Wu, T. D., & Hanania, N. A. (2025). Patient-reported treatment outcomes in ME/CFS and long COVID. Proceedings of the National Academy of Sciences, 122(7), e2426874122. https://doi.org/10.1073/pnas.2426874122
  6. Durstenfeld, M. S., Sun, K., Tahir, P., Peluso, M. J., Deeks, S. G., Aras, M. A., Grandis, D. J., Long, C. S., Beatty, A., & Hsue, P. Y. (2024). The persistence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after SARS-CoV-2 infection: A systematic review and meta-analysis. Journal of Infection, 89(6), 106297. https://doi.org/10.1016/j.jinf.2024.106297
  7. Li, Y., Yang, J., Chau, C. I., Shi, J., Chen, X., Hu, H., Chan, K. W., So, K. F., Chen, H., Chong, B. H., & Zhang, J. N. (2023). Is there a role for traditional and complementary medicines in managing chronic fatigue? A systematic review of randomized controlled trials. Frontiers in Pharmacology, 14, 1266803. https://doi.org/10.3389/fphar.2023.1266803
  8. Liu, X., Liu, S., Ren, R., Wang, X., Han, C., & Liu, Z. (2024). A cross-sectional study exploring the relationship between symptoms of anxiety/depression and P50 sensory gating in adult patients diagnosed with chronic fatigue syndrome/myalgic encephalomyelitis. Frontiers in Neuroscience, 17, 1286340. https://doi.org/10.3389/fnins.2023.1286340
  9. Loades, M. E., Read, R., Smith, L., Higson-Sweeney, N. T., Laffan, A., Stallard, P., Kessler, D., & Crawley, E. (2021). How common are depression and anxiety in adolescents with chronic fatigue syndrome (CFS) and how should we screen for these mental health co-morbidities? A clinical cohort study. European Child & Adolescent Psychiatry, 30, 1733–1743. https://doi.org/10.1007/s00787-020-01646-w
  10. Maksoud, R., Magawa, C., Eaton-Fitch, N., Thapaliya, K., & Marshall-Gradisnik, S. (2023). Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review. BMC Medicine, 21, 189. https://doi.org/10.1186/s12916-023-02893-9
  11. National Institute for Health and Care Excellence. (2021). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: Diagnosis and management. NICE guideline [NG206]. https://www.nice.org.uk/guidance/ng206
  12. National Institute of Neurological Disorders and Stroke. (2024). ME/CFS research roadmap: Report of the NANDS Council Working Group. NINDS. https://www.ninds.nih.gov/sites/default/files/2024-05/Report%20of%20the%20MECFS%20Research%20Roadmap%20Working%20Group%20of%20Council_508C.pdf
  13. Park, J., Lim, S., Kim, Y., Lee, J., Choi, H., Kim, S., Park, K., & Moon, J. (2024). Systematic review of fatigue severity in ME/CFS patients: Insights from randomized controlled trials. Journal of Translational Medicine, 22, 569. https://doi.org/10.1186/s12967-024-05349-7
  14. Renz-Polster, H., Tremblay, M. E., Bienzle, D., & Fischer, J. E. (2022). The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: The case for neuroglial failure. Frontiers in Cellular Neuroscience, 16, 888232. https://doi.org/10.3389/fncel.2022.888232
  15. Sapra, A., & Bhandari, P. (2023). Chronic fatigue syndrome. In StatPearls [Internet]. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK557676/
  16. Todhunter-Brown, A., Bayes, H., Beaton, N., Brydges, R., Carson, A., Chalder, T., Collin, S. M., Davenport, T., Davis, K. A., Dougall, N., English, A., Finnerup, N. B., Hunt, D., Jason, L. A., Knoop, H., Maxted, C., Mengshoel, A. M., Moss-Morris, R., Newton, F.,... & Weir, C. J. (2025). Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: An evidence map. Health Technology Assessment. National Institute for Health and Care Research. https://www.ncbi.nlm.nih.gov/books/NBK613143/
  17. Tschopp, R., König, R. S., Rejmer, P., Paris, D. H., Müller, A., Schüpbach, R. L., Schreier, D. R., & Iff, S. (2024). Identifying the mental health burden in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients in Switzerland: A pilot study. Heliyon, 10(5), e27031. https://doi.org/10.1016/j.heliyon.2024.e27031
  18. Vahratian, A., Lin, J. S., Bertolli, J., & Unger, E. R. (2023). Myalgic encephalomyelitis/chronic fatigue syndrome in adults: United States, 2021–2022. NCHS Data Brief, no 488. National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db488.htm
  19. Vernon, S. D., Hartle, M., Sullivan, K., Bell, J., Abbaszadeh, S., Unutmaz, D., & Bateman, L. (2025). Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: A report from the observational RECOVER-adult study. Journal of General Internal Medicine, 40, 1085–1094. https://doi.org/10.1007/s11606-024-09290-9
  20. Walitt, B., Singh, K., LaMunion, S. R., Hallett, M., Jacobson, S., Chen, K., Enose-Akahata, Y., Apps, R., Barb, J. J., Bedard, P., Brychta, R. J., Buckley, A. W., Burbelo, P. D., Calco, B., Cathay, B., Chen, L., Chigurupati, S., Chen, J., Cheung, F.,... & Nath, A. (2024). Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome. Nature Communications, 15(1), 907. https://doi.org/10.1038/s41467-024-45107-3
  21. Xiong, R., Gunter, C., Fleming, E., Vernon, S. D., Bateman, L., Unutmaz, D., & Oh, J. (2023). Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients. Cell Host & Microbe, 31(2), 273–287.e5. https://doi.org/10.1016/j.chom.2023.01.001
  22. Yoon, J. H., Park, S. E., Kang, Y. E., Ahn, Y., Lee, E., & Son, C. G. (2023). The demographic features of fatigue in the general population worldwide: A systematic review and meta-analysis. Frontiers in Public Health, 11, 1192121. https://doi.org/10.3389/fpubh.2023.1192121
  23. Zhao, T., Cox, I. A., Ahmad, H., Campbell, J. A., Hensher, M., Palmer, A. J., & de Graaff, B. (2025). Burden of disease in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A scoping review. Applied Health Economics and Health Policy, 23, 15–32. https://doi.org/10.1007/s40258-025-01006-2